Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).
about
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaAnti-IgE for chronic asthma in adults and childrenAnti-IgE for chronic asthma in adults and childrenPharmacotherapy and airway remodelling in asthma?Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewDose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysisChronic asthma.Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerNational Athletic Trainers' Association position statement: management of asthma in athletes.Cost effectiveness of guideline advice for children with asthma: a literature review.Inhaled CorticosteroidsRisk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.Clinical considerations in the use of inhaled corticosteroids for asthma.Tiotropium bromide.Respiratory medicine.Treatment strategies for bronchial asthma: an update.Long-acting inhaled beta(2)-agonist therapy in asthma.Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.Addition of theophylline or increasing the dose of inhaled corticosteroid in symptomatic asthma: a meta-analysis of randomized controlled trials.Antagonism of long-acting beta2-adrenoceptor agonism.Combined budesonide/formoterol turbuhaler treatment of asthma.Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma.Combination therapy: appropriate for everyone?Clinical dose-response relationship of fluticasone propionate in adults with asthma.β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoidsLong-acting beta2-agonists: comparative pharmacology and clinical outcomes.An overview of the current asthma disease management guidance.Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthmaAdd-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotypeComparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.Combined Beta-agonists and corticosteroids do not inhibit extracellular matrix protein production in vitroDoes bronchial hyperresponsiveness in asthma matter?Recent developments in asthma managementHealth care utilization and medical costs for childhood asthma in Taiwan: using Taiwan National Health Insurance Research DatabaseAdding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
P2860
Q24235964-AB2042ED-71B9-46B2-A1DA-3DD0691AA732Q24240464-4F7B2C4B-87A4-4E4B-AE2F-C3EF2B1BCA13Q24244152-AE4CE03D-FEBA-4DE8-9840-1D65CA5083BFQ24246484-EB016B96-20CA-42C7-9883-F86A414840D3Q24247152-5ED2A0F6-B5EC-4B02-99A4-A709D18E6F92Q24678822-CB7C64FF-07BE-4466-A1E4-1851F7F55AD7Q24794527-CD8F5BF3-6F88-4B05-B40C-5DE02CD08E93Q28345332-3EB4EF12-8616-4CB4-B046-A3D8CFBB83C9Q28362642-5B1595BB-2EFF-410C-AFE2-D690818994B7Q28596628-0B15F2BD-443D-4E09-A0CF-238080A0E37CQ28769235-21C67CFD-1DE5-4DD7-83B1-D1E9C1E540B6Q30868889-3647C063-8A69-4C29-8647-EFEF826E1780Q33664193-FFB5E930-B726-49A1-8959-BF2568A81007Q33803143-2A0F7906-81CE-45EE-B10B-B0F056DBA852Q34181951-CA772806-FE1D-4120-86F6-B014FAC433BCQ34186812-44ACEFD9-AA91-4355-B3A8-CCD94D7A220FQ34204383-D7D4C934-6AAC-40A4-849C-514C272460DBQ34247647-4BA596AB-8A53-4A5B-A337-3E2D4DBDCA9FQ34342572-E13FA99E-385C-4802-8867-1D470022714BQ34392656-8A26C60C-ACC6-495F-B07A-1B961A50081AQ34414680-F253E599-2E5B-4A0C-BC9F-F53C00542BB5Q34523871-55FF01B5-B3B4-4502-9FFB-E54E2778250DQ34635514-758B7FC9-13E0-4730-B8DB-30076A9FD14AQ34866359-B22F8448-8144-4CF1-A3F0-1CC733ECDE59Q35009462-67DACF91-EF86-4BC9-B01A-602FD0A61FE5Q35040750-87DEC041-20F8-44D9-BB53-B7272D1191DEQ35180953-9D34717B-FC4E-4677-BBE9-E96F825F90FAQ35564127-F7F9D5FB-B9BD-435F-9068-44A3147F6F48Q35621371-640A912D-64CF-493F-9B65-BD8095751309Q35627925-4D541C2E-6458-42CD-8306-FE0F184A1184Q35816308-D9D4A897-7E94-4320-9FB8-A72B885918B7Q35825597-C6EC7CE2-3EE9-43B7-90AA-A82ADCEDBBE1Q35825639-4E4296C1-79C5-40C3-93CF-C0E39C4251CBQ35825799-2F6E4915-3615-4BA5-920B-8FCE339BE7D1Q35829987-9E709D16-69B4-4563-8A16-FB9DE0BB308BQ35839483-BB9C6854-1CA1-483B-8218-7B32E92B1DBDQ36067978-713B35A2-919F-4B3F-A94B-D8F325EF3F7AQ36120792-B77B1F5B-4F07-416A-9865-C3A97ADB1842Q36183977-50FB451C-E185-4BDF-8C1C-FCC9446F16E3Q36246222-EFD3C89B-4270-4897-9473-21182BFD2394
P2860
Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@ast
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@en
type
label
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@ast
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@en
prefLabel
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@ast
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@en
P2093
P2860
P1433
P1476
Meta-analysis of increased dos ...... n symptomatic asthma (MIASMA).
@en
P2093
P2860
P304
P356
10.1136/BMJ.320.7246.1368
P407
P577
2000-05-01T00:00:00Z